Cargando…
Bioreactors get personal
Adoptive cell transfer immunotherapy against melanoma is highly effective. However, this therapy has seen limited dissemination, mainly due to the complexity and costs of cell expansion protocols. Two bioreactors have recently been described that simplify and streamline the production of individuali...
Autores principales: | Somerville, Robert P.T., Dudley, Mark E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518529/ https://www.ncbi.nlm.nih.gov/pubmed/23243620 http://dx.doi.org/10.4161/onci.21206 |
Ejemplares similares
-
Mimotope vaccine efficacy gets a "boost" from native tumor antigens
por: Buhrman, Jonathan D., et al.
Publicado: (2013) -
Getting by with a little help from the right CD4(+) T cells
por: Hoepner, Sabine, et al.
Publicado: (2013) -
Trick and treat: Ambushing recurrent tumors before they get out of the door
por: Boisgerault, Nicolas, et al.
Publicado: (2014) -
Specificity may be overrated in cancer immunotherapy: Getting to know the nonspecific side of memory T Cells
por: Sckisel, Gail D., et al.
Publicado: (2012) -
On your marks, get SET(D1A): the race to protect stalled replication forks
por: Begum, Shabana, et al.
Publicado: (2018)